Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS MSCI ACWI Socially Responsible UCITS ETF USD dis
IE00BDR55364 · IE00BDR55364 · USD · domicile Ireland
Equity · Sustainable / ESGSFDR art. 8
Index tracked: MSCI ACWI SRI Low Carbon Select 5% Issuer Capped Total Return Net USD
- TER
- 0.25%+ trans. 0.00%
- Fund size
- —
- Tracking difference
- −0.15%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingsemi-annual
Launch 25 Jun 2019 · costs from the KID as of 26 Aug 2026 · 1 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Il Fondo è a gestione passiva e mira a replicare la performance dell'indice MSCI ACWI SRI Low Carbon Select 5% Issuer Capped Index (Net Return) (l'«Indice»).
L'Indice è concepito per misurare l'andamento di società globali best-in-class in termini di responsabilità ambientale, sociale e di corporate governance (ESG) evitando al contempo le società con un impatto sociale o ambientale negativo. Questo approccio bestin-class esclude almeno il 20% dei titoli con merito di credito più basso rispetto all'universo standard dell'Indice. Si prevede che il…
Performance since series start (in euro) — base 100
25 Jun 2019 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +25.6% |
| 3 years | +60.3% |
| 5 years | +64.6% |
| 10 years | series too young |
| Since series start | +144.9% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 14.26% | 13.99% | 15.48% |
| Max drawdown | −10.43% | −18.73% | −32.90% |
| Sharpe | 1.38 | 1.09 | 0.47 |
| Sortino | 2.07 | 1.58 | 0.67 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BDR55364 · IE00BDR553641
RebalixIE00BDR55364 · IE00BDR55364 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +16.31% | +16.45% | −0.14% |
| 2024 | +18.00% | +18.18% | −0.18% |
| 2023 | +26.90% | +27.03% | −0.13% |
| 2022 | −23.85% | −24.43% | +0.58% |
| 2021 | +21.64% | +21.73% | −0.09% |
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.2738 USD (0.98% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.2738 | — |
| 2025 | 2 | 0.2518 | +1.20% |
| 2024 | 1 | 0.1522 | +0.85% |
| 2023 | 2 | 0.2288 | +1.59% |
| 2022 | 2 | 0.2225 | +1.16% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
W7A0 · Tradegate Exchange
+ 2 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BDR55364
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BDR55364
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BDR55364 · IE00BDR553642